Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.

Documenti analoghi

• Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
  di: Waitumbi, John N., et al.
  Pubblicazione: (2009)
• Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
  di: Polhemus, Mark E., et al.
  Pubblicazione: (2009)
• Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines: Randomized, double-blind study in malaria-naïve adults
  di: Leroux-Roels, Geert, et al.
  Pubblicazione: (2014)
• A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
  di: Lell, Bertrand, et al.
  Pubblicazione: (2009)
• Induction of Plasmodium falciparum-Specific CD4(+) T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)
  di: Agnandji, Selidji T., et al.
  Pubblicazione: (2011)